jueves, 22 de agosto de 2019

Gilead contests government patents on a controversial HIV prevention pill

Gilead contests government patents on a controversial HIV prevention pill

Daily Recap

STAT Plus: Gilead challenges U.S. government patents on a controversial HIV prevention pill

By ED SILVERMAN


ERIC RISBERG/AP
The drug maker claims that four patents held by the federal government for using the Truvada pill to prevent HIV are not valid.

No hay comentarios: